| 达沙替尼治疗伊马替尼引起肝功能异常的慢性粒细胞白血病1例报告 |
| |
| 引用本文： | 田锋奇,郜娜,李磊,赵秀莉.达沙替尼治疗伊马替尼引起肝功能异常的慢性粒细胞白血病1例报告[J].第二军医大学学报,2016,37(1):129-130. |
| |
| 作者姓名： | 田锋奇 郜娜 李磊 赵秀莉 |
| |
| 作者单位： | 郑州大学附属肿瘤医院,河南省肿瘤医院药学部,郑州450008 |
| |
| 摘 要： | 1 病例资料 患者,女,60岁,2013年2月诊断为慢性粒细胞白血病(chronic myelocytic leukemia,CML),间断应用羟基脲治疗.2014年4月20日,因“乏力、纳差、腹胀”入院治疗,入院时查血常规,白细胞(WBC)计数121×109/L,血红蛋白(Hb)浓度103 g/L,血小板(PLT)计数708×109/L.外周血:中幼粒细胞比例0.05,晚幼粒细胞比例0.12,嗜酸粒细胞比例0.06,嗜碱粒细胞比例0.05.骨髓象:有核细胞增生极度活跃,粒系极度增生,原始粒细胞比例0.002 8,红系受抑,巨核细胞56个.染色体分析报告结果:46,t(9;22).
|
| 关 键 词： | 达沙替尼 慢性粒细胞白血病 酪氨酸激酶抑制剂 |
| 收稿时间： | 2015/6/23 0:00:00 |
| 修稿时间： | 2015/8/31 0:00:00 |
Dasatinib tablets in treating chronic myelocytic leukemia patient with imatinib-induced hepatic dysfunction: a case report |
| |
| TIAN Feng-qi,GAO N,LI Lei and ZHAO Xiu-li.Dasatinib tablets in treating chronic myelocytic leukemia patient with imatinib-induced hepatic dysfunction: a case report[J].Academic Journal of Second Military Medical University,2016,37(1):129-130. |
| |
| Authors: | TIAN Feng-qi GAO N LI Lei and ZHAO Xiu-li |
| |
| Institution: | Department of Pharmacy,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou HENAN 450008,Department of Pharmacy,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou HENAN 450008,Department of Pharmacy,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou HENAN 450008,Department of Pharmacy,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou HENAN 450008 |
| |
| Abstract: | |
| |
| Keywords: | Dasatinib Chronic myelocytic leukemia Tyrosine kinase inhibitor |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《第二军医大学学报》浏览原始摘要信息 |
| 点击此处可从《第二军医大学学报》下载免费的PDF全文 |
|
